Related Experiment Video
Updated: Aug 17, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Antithrombotic and thrombolytic therapy: from evidence to application: the Seventh ACCP Conference on Antithrombotic
Holger J Schünemann1, Deborah Cook, Jeremy Grimshaw
1Department of Medicine, University at Buffalo, ECMC-CC142, 462 Grider St, Buffalo, NY 14215, USA. HJS@buffalo.edu
Insights
Implementing practice guidelines for antithrombotic and thrombolytic therapy requires careful resource allocation. Computer reminders and patient-mediated interventions show promise, but more research is needed for consistent benefits.
Area of Science:
- Medical Guidelines
- Evidence-Based Medicine
- Thrombosis Management
Background:
- Practice guidelines are crucial for optimizing antithrombotic and thrombolytic therapy.
- Effective implementation strategies are essential for guideline uptake and patient benefit.
- The 7th ACCP Conference on Antithrombotic and Thrombolytic Therapy addressed these implementation challenges.
Purpose of the Study:
- To evaluate the effectiveness of various implementation strategies for practice guidelines.
- To guide resource allocation for promoting the adoption of antithrombotic and thrombolytic therapy guidelines.
- To identify strategies with consistent and unequivocal benefits.
Main Methods:
- Review of implementation strategies based on Grade 1 and Grade 2 recommendations.
- Assessment of resource investment versus benefit for different strategies.
- Consideration of feasibility, acceptability, and cost in practice settings.
Main Results:
- Distribution of educational material is recommended with appreciable resources (Grade 2B).
- Computer reminders (Grade 2A) and patient-mediated interventions (Grade 2B) are suggested for significant resource investment.
- Educational meetings, audit and feedback, and outreach visits require fewer resources (Grade 2B).
Conclusions:
- Few implementation strategies offer unequivocal and consistent benefits for resource investment.
- Optimizing antithrombotic and thrombolytic therapy requires further research into effective guideline implementation.
- Tailoring strategies to practice settings is important for successful guideline adoption.
Abstract:
This chapter about implementation strategies for practice guidelines is part of the 7th ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based Guidelines. Grade 1 recommendations are strong and indicate that the benefits do, or do not, outweigh risks, burden, and costs. Grade 2 suggests that feasibility, acceptability and cost related to implementation strategies may lead to different choices depending on the practice setting (for a full understanding of the grading see Guyatt et al, CHEST 2004; 126:179S-187S). To encourage uptake of guidelines to reduce thrombosis, we recommend that appreciable resources be devoted to distribution of educational material (Grade 2B). We suggest that few resources be devoted to educational meetings (Grade 2B), to audit and feedback (Grade 2B), or to educational outreach visits (Grade 2B) to encourage uptake of the guidelines. We suggest that appreciable resources be devoted to computer reminders (Grade 2A) and to patient-mediated interventions (Grade 2B) to encourage uptake of the guidelines. This review suggests that there are few implementation strategies that are of unequivocal, consistent benefit, and that are clearly and consistently worth resource investment. Fully informed decisions will require additional research to identify effective guideline implementation strategies to optimize antithrombotic and thrombolytic therapy.
More Related Videos
09:52Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
Published on: January 15, 2017
06:38The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
Published on: December 19, 2025
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease V: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care